These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 13365993)

  • 1. [Problem of hormesis induced by synthetic antituberculosis agents].
    POLSTER M
    G Ital Chemioter; 1956; 3(1-2):33-6. PubMed ID: 13365993
    [No Abstract]   [Full Text] [Related]  

  • 2. Sensitivity of Mycobacterium tuberculosis to para-aminosalicylic acid, isoniazid, and the P.A.S. salt of isoniazid.
    DUNBAR JM; RITCHIE RT
    Lancet; 1957 Sep; 273(6996):612-3. PubMed ID: 13476667
    [No Abstract]   [Full Text] [Related]  

  • 3. The influence of antituberculous drugs upon the oxygen consumption of mycobacteria.
    SUZUKI T
    Sci Rep Res Inst Tohoku Univ Med; 1955 Jan; 6(1):89-95. PubMed ID: 13246659
    [No Abstract]   [Full Text] [Related]  

  • 4. [Studies on the biological properties of the laboratory strains of Mycobacterium avium. 3rd Report. Susceptibility to para-aminosalicylic acid, isoniazid and neotetrazolium].
    TAKEYA K; YAMAURA K; IKEGAMI W
    Kekkaku; 1960 Feb; 35():88-91. PubMed ID: 13836688
    [No Abstract]   [Full Text] [Related]  

  • 5. [Resistance of Mycobacterium tuberculosis to antituberculotics in synthetic culture media].
    BANYASZ T
    Tuberkulozis; 1957; 10(5-6):107-9. PubMed ID: 13496268
    [No Abstract]   [Full Text] [Related]  

  • 6. [Effect of combined treatment with streptomycin, PAS and isoniazid on resistance of Mycobacterium tuberculosis to streptomycin and isoniazid].
    JANKOV M
    Hig Cas Hig Mikrobiol Epidemiol Sanit Teh; 1955; 7(1-4):228-34. PubMed ID: 13405406
    [No Abstract]   [Full Text] [Related]  

  • 7. Incidence of resistance to primary and secondary antituberculosis drugs in isolates of M. tuberculosis from cases of pulmonary tuberculosis.
    Kothadia SN; Sengupta SR
    Indian J Chest Dis Allied Sci; 1984; 26(3):163-6. PubMed ID: 6443608
    [No Abstract]   [Full Text] [Related]  

  • 8. Identification and drug sensitivity of tubercle bacilli from Addis Ababa, Ethiopia.
    Pattyn SR; Keterew W; Hadgu AG; van den Breen L
    Ethiop Med J; 1979 Oct; 17(4):119-22. PubMed ID: 546655
    [No Abstract]   [Full Text] [Related]  

  • 9. Studies on the drug resistance in Mycobacterium tuberculosis var. hominis.
    MIURA K; NODA Y; TSUKAMURA M
    J Antibiot (Tokyo); 1956 Sep; 9(5):182-5. PubMed ID: 13385195
    [No Abstract]   [Full Text] [Related]  

  • 10. [Interaction of antitubercular agents. I. Combined action of rifampicin, isonicotinic acid hydrazide, streptomycin and para-aminosalicylic acid on the growth of strains of tubercle bacilli].
    Janowiec M; Zwolska-Kwiek Z; Wiśniewska A; Wróblewska H
    Pneumonol Pol; 1977 Jun; 45(6):425-30. PubMed ID: 406600
    [No Abstract]   [Full Text] [Related]  

  • 11. An unusual case of bacterial resistance to antibiotics with successful reversal by use of isonicotinic acid hydrazide and para-aminosalicylic acid.
    GEORGE WL; ZSAKO S
    Ohio State Med J; 1957 Sep; 53(9):1023-7. PubMed ID: 13465090
    [No Abstract]   [Full Text] [Related]  

  • 12. Studies on the drug resistance in mycobacteria with genetic reference; on the frequency of appearance of PAS-resistant mutants in Mycobacterium tuberculosis var. hominis simultaneously resistant to streptomycin and isoniazid.
    TSUKAMURA M
    J Antibiot (Tokyo); 1956 Sep; 9(5):186-90. PubMed ID: 13385196
    [No Abstract]   [Full Text] [Related]  

  • 13. Resistance of tubercle bacilli: a brief review in relation to a recent study in Ethiopia.
    Teklu B
    Ethiop Med J; 1979 Oct; 17(4):123-5. PubMed ID: 546656
    [No Abstract]   [Full Text] [Related]  

  • 14. [New laboratory accomplishments in thoracic pathology].
    CETRANGOLO A
    Rev Med Cubana; 1956 May; 67(5):418-25. PubMed ID: 13371028
    [No Abstract]   [Full Text] [Related]  

  • 15. RESISTANT tubercle bacilli.
    Lancet; 1957 Apr; 272(6973):825-6. PubMed ID: 13417612
    [No Abstract]   [Full Text] [Related]  

  • 16. [IZOPASK®--THE NEW COMBINED ANTITUBERCULAR PREPARATION].
    Tuberk Biolezni Legkih; 2010; (4):61-4. PubMed ID: 27534031
    [No Abstract]   [Full Text] [Related]  

  • 17. [Variations of isoniazid metabolism following administration of other antituberculous drugs].
    ROSSINI G; NESSI G
    G Ital Della Tuberc; 1956; 10(2):82-8. PubMed ID: 13331182
    [No Abstract]   [Full Text] [Related]  

  • 18. [Resistance determination in practice in a tuberculosis clinic].
    ERMISCH K; ERMISCH U
    Zentralbl Bakteriol Orig; 1955 Dec; 164(8):566-76. PubMed ID: 13371902
    [No Abstract]   [Full Text] [Related]  

  • 19. [Incidence of resistance of Koch bacillus to antibiotics during primary infection].
    BRETON A; GAUDIER B; PIERRET R
    Arch Fr Pediatr; 1956; 13(6):664-74. PubMed ID: 13373449
    [No Abstract]   [Full Text] [Related]  

  • 20. [Studies on double or triple resistance of Mycobacterium tuberculosis. 1. The rate of appearance of double or triple resistance, and the effect of drugs on the appearance of this resistance].
    KUROIWA K
    Kekkaku; 1960 Jul; 35():492-8. PubMed ID: 13755309
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.